ES2158684T3 - Procedimiento para la preparacion de acido 3,4-epoxibutirico quiral y sus sales. - Google Patents

Procedimiento para la preparacion de acido 3,4-epoxibutirico quiral y sus sales.

Info

Publication number
ES2158684T3
ES2158684T3 ES98929880T ES98929880T ES2158684T3 ES 2158684 T3 ES2158684 T3 ES 2158684T3 ES 98929880 T ES98929880 T ES 98929880T ES 98929880 T ES98929880 T ES 98929880T ES 2158684 T3 ES2158684 T3 ES 2158684T3
Authority
ES
Spain
Prior art keywords
acid
preparation
epoxibutric
salts
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98929880T
Other languages
English (en)
Inventor
Il-Suk Byun
Kyung-Il Kim
Yoon-Hwan Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lotte Fine Chemical Co Ltd
Original Assignee
Samsung Fine Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samsung Fine Chemicals Co Ltd filed Critical Samsung Fine Chemicals Co Ltd
Application granted granted Critical
Publication of ES2158684T3 publication Critical patent/ES2158684T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/48Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La invención se refiere al procedimiento para la preparación del ácido quiral 3,4-epoxibutírico representado por la fórmula (1) y la sal de éste, en el que se emplea como materia prima la hidroxibutirolactona-(S)-3-activada u otro material barato para realizar una reacción eficaz de apertura de anillo y una epoxidación con una inversión del centro quiral.
ES98929880T 1997-07-16 1998-06-17 Procedimiento para la preparacion de acido 3,4-epoxibutirico quiral y sus sales. Expired - Lifetime ES2158684T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970033208 1997-07-16
KR1019970057812A KR100247563B1 (ko) 1997-07-16 1997-11-03 키랄3,4-에폭시부티르산및이의염의제조방법

Publications (1)

Publication Number Publication Date
ES2158684T3 true ES2158684T3 (es) 2001-09-01

Family

ID=26632933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98929880T Expired - Lifetime ES2158684T3 (es) 1997-07-16 1998-06-17 Procedimiento para la preparacion de acido 3,4-epoxibutirico quiral y sus sales.

Country Status (9)

Country Link
US (1) US6232478B1 (es)
EP (1) EP1000049B1 (es)
JP (1) JP3306549B2 (es)
KR (1) KR100247563B1 (es)
CN (1) CN1264372A (es)
CA (1) CA2296316A1 (es)
DE (1) DE69800805T2 (es)
ES (1) ES2158684T3 (es)
WO (1) WO1999003850A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100255039B1 (ko) * 1997-07-28 2000-05-01 박영구 L-카르니틴의제조방법
US20100108118A1 (en) * 2008-06-02 2010-05-06 Daniel Luch Photovoltaic power farm structure and installation
US20090293941A1 (en) * 2008-06-02 2009-12-03 Daniel Luch Photovoltaic power farm structure and installation
KR20000065995A (ko) * 1999-04-12 2000-11-15 박영구 키랄 3-히드록시-γ-부티로락톤의 제조방법
US7244745B2 (en) 2002-08-30 2007-07-17 Memory Pharmaceuticals Corp. Heterocyclic compounds, methods for the preparation thereof, and uses thereof
MXPA05003317A (es) 2002-09-25 2005-07-05 Memory Pharm Corp Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
SG134333A1 (en) 2003-11-12 2007-08-29 Phenomix Corp Heterocyclic boronic acid compounds
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
EP1735306A2 (en) 2004-03-25 2006-12-27 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US9236512B2 (en) 2006-04-13 2016-01-12 Daniel Luch Collector grid and interconnect structures for photovoltaic arrays and modules
US9865758B2 (en) 2006-04-13 2018-01-09 Daniel Luch Collector grid and interconnect structures for photovoltaic arrays and modules
US9408816B2 (en) 2006-12-26 2016-08-09 Pharmacyclics Llc Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
CN102374987A (zh) * 2010-08-17 2012-03-14 上海新先锋药业有限公司 一种4-乙酰氧基氮杂环丁酮中间体的含量测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1189069B (it) * 1986-03-14 1988-01-28 Donegani Guido Ist Processo per la preparazione biotecnologica della l(-)-carnitina cloruro
JP2834501B2 (ja) * 1989-11-25 1998-12-09 鐘淵化学工業株式会社 3,4―エポキシ酪酸エステルの製法および中間体
CA2049536C (en) 1991-05-13 1999-07-06 Rawle I. Hollingsworth Process for the preparation of 3,4-dihydroxybutanoic acid and salts thereof

Also Published As

Publication number Publication date
EP1000049A1 (en) 2000-05-17
JP2001508082A (ja) 2001-06-19
KR19990013236A (ko) 1999-02-25
DE69800805D1 (de) 2001-06-21
KR100247563B1 (ko) 2000-04-01
US6232478B1 (en) 2001-05-15
JP3306549B2 (ja) 2002-07-24
CA2296316A1 (en) 1999-01-28
EP1000049B1 (en) 2001-05-16
CN1264372A (zh) 2000-08-23
DE69800805T2 (de) 2001-11-15
WO1999003850A1 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
ES2158684T3 (es) Procedimiento para la preparacion de acido 3,4-epoxibutirico quiral y sus sales.
BR0110492A (pt) Composto, composição farmacêutica que compreende esse composto, processo para a preparação de composição farmacêutica, utilização do composto e processo para a preparação do composto
DK0382173T3 (da) Substans PF 1022, fremgangsmåde til fremstilling heraf og anthelmintisk præparat indeholdende denne
ES2187598T3 (es) Metodos para producir proteinas de fusion.
AR003962A1 (es) Dihidrodibenzo/b,f/azepinas útiles en el tratamiento de algunos desórdenes del sistema nervioso central y períferico, método para preparar dichos compuestos y sus composiciones farmacéuticas,y, sus usos
MX9304027A (es) Variante de al enzima lipasa y metodo para su produccion.
BR9705447A (pt) Microcápsulas usando poliisocianatos de iminooxadiazinadiona
ES2171156T3 (es) Produccion de vacunas por ingenieria genetica para sida y otras enfermedades retroviricas.
ES2020539B3 (es) Liquidos de escribir acuosos, como su proceder para su fabricacion
BR9813022A (pt) Derivados de ésteres hidroxiacéticos, seu processo de preparação e sua utilização como intermediários de sìntese
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES405663A1 (es) Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina.
EP0163623A3 (en) Cell surface protein, process for its preparation, as well as the use of a cell surface protein thus obtained
BR0115036A (pt) Processo para a preparação de um composto
IT7928219A0 (it) Procedimento perfezionato per laproduzione di cumene.
BR9914907A (pt) Cápsula mineral, processo para sua preparação, e, utilização das cápsulas
DE3066574D1 (en) Optically pure heterocyclic amino acids, process for their preparation and their use
ATE272436T1 (de) Mikrofiltration unter verwendung von aktivkohle
ATE69604T1 (de) Verfahren zur herstellung von 1-hydroxy-2pyridonen.
FR2629454B1 (fr) Procede de preparation de 1-methoxy-2,4-diamino-benzene, de certains de leurs composes et des produits intermediaires, ainsi que des teintures en solution aqueuse pour des fibres de keratine
ES2037763T3 (es) Metodo para preparar compuestos no naturales afines a la ceramida.
FR2608607B1 (fr) Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
BR9811855A (pt) Processo para preparação de ácido l-ascórbico
ES2043610T3 (es) Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno.
PT1257552E (pt) Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1000049

Country of ref document: ES